|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G16B 20/00 |
| (11) | Number of the document | 3639170 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18738407.8 |
| Date of filing the European patent application | 2018-06-12 | |
| (97) | Date of publication of the European application | 2020-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/037018 |
| Date | 2018-06-12 |
| (87) | Number | WO 2018/231772 |
| Date | 2018-12-20 |
| (30) | Number | Date | Country code |
| 201762518787 P | 2017-06-13 | US | |
| 201762598440 P | 2017-12-13 | US |
| (72) |
FRENKEL, Feliks, RU
KOTLOV, Nikita, RU
BAGAEV, Alexander, RU
ARTOMOV, Maksym, US
ATAULLAKHANOV, Ravshan, RU
|
| (73) |
BostonGene Corporation,
95 Sawyer Road, Suite 500, Waltham, MA 02453,
US
|
| (54) | SYSTEMS AND METHODS FOR IDENTIFYING RESPONDERS AND NON-RESPONDERS TO IMMUNE CHECKPOINT BLOCKADE THERAPY |
| SYSTEMS AND METHODS FOR IDENTIFYING RESPONDERS AND NON-RESPONDERS TO IMMUNE CHECKPOINT BLOCKADE THERAPY |